Inhibrx Biosciences, Inc. INBX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s accounts payable?
- Inhibrx Biosciences, Inc. (INBX) reported accounts payable of $8.76M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s accounts payable changed year-over-year?
- Inhibrx Biosciences, Inc.'s accounts payable decreased by 1.5% year-over-year, from $8.89M to $8.76M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.